Skip to main content
PMC home page
Occupational and Environmental Medicine logoLink to Occupational and Environmental Medicine
. 1999 Feb;56(2):106–109. doi: 10.1136/oem.56.2.106

Dose dependent reduction of erythroid progenitor cells and inappropriate erythropoietin response in exposure to lead: new aspects of anaemia induced by lead

W Osterode, U Barnas, K Geissler
PMCID: PMC1757702  PMID: 10448314

Abstract

OBJECTIVE: To determine whether haematopoietic progenitor cells and erythropoietin (EPO), which is an essential humoral stimulus for erythroid progenitor (BFU-E) cell differentiation, are affected by lead intoxication. METHODS: In male subjects chronically exposed to lead with and without anaemia, pluripotent (CFU-GEMM), BFU-E and granulocyte/macrophage (CFU-GM) progenitor cell counts in peripheral blood were measured with a modified clonal assay. Lead concentrations in blood (PbB) and urine (PbU) were measured by the atomic absorption technique, and EPO was measured with a modified radioimmunoassay. RESULTS: PbB in the subjects exposed to lead ranged from 0.796 to 4.4 mumol/l, and PbU varied between 0.033 and 0.522 mumol/l. In subjects exposed to lead with PbB > or = 2.896 mumol/l (n = 7), BFU-E cells were significantly reduced (p < 0.001) whereas the reduction in CFU-GM cells was only of borderline significance (p = 0.037) compared with the age matched controls (n = 20). The CFU-GEMM cells remained unchanged. Furthermore, BFU-E and CFU-GM cells were reduced in a dose dependent fashion, with increasing PbB or PbU, respectively. In the subjects exposed to lead EPO was in the normal range and did not increase in the presence of anaemia induced by lead. No correlations existed between EPO and PbB, PbU, or progenitor cells. CONCLUSION: The data suggest new aspects of lead induced anaemia besides the currently acknowledged shortened life span of erythrocytes and inhibition of haemoglobin synthesis. Two additional mechanisms should be considered: the reduction of BFU-E cells, and inappropriate renal EPO production in the presence of severe exposure to lead, which would lead to an inadequate maturation of BFU-E cells.

 

Full Text

The Full Text of this article is available as a PDF (126.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Caro J., Erslev A. J. Biologic and immunologic erythropoietin in extracts from hypoxic whole rat kidneys and in their glomerular and tubular fractions. J Lab Clin Med. 1984 Jun;103(6):922–931. [PubMed] [Google Scholar]
  2. Dorie M. J., Maloney M. A., Patt H. M. Turnover of circulating hematopoietic stem cells. Exp Hematol. 1979 Oct;7(9):483–489. [PubMed] [Google Scholar]
  3. Ebert P. S., Hess R. A., Frykholm B. C., Tschudy D. P. Succinylacetone, a potent inhibitor of heme biosynthesis: effect on cell growth, heme content and delta-aminolevulinic acid dehydratase activity of malignant murine erythroleukemia cells. Biochem Biophys Res Commun. 1979 Jun 27;88(4):1382–1390. doi: 10.1016/0006-291x(79)91133-1. [DOI] [PubMed] [Google Scholar]
  4. Erslev A. J., Caro J. Physiologic and molecular biology of erythropoietin. Med Oncol Tumor Pharmacother. 1986;3(3-4):159–164. doi: 10.1007/BF02934992. [DOI] [PubMed] [Google Scholar]
  5. GRIGGS R. C. LEAD POISONING: HEMATOLOGIC ASPECTS. Prog Hematol. 1964;4:117–137. [PubMed] [Google Scholar]
  6. Geissler K., Hinterberger W., Jäger U., Bettelheim P., Neumann E., Haas O., Ambros P., Chott A., Radaszkiewicz T., Lechner K. Deficiency of pluripotent hemopoietic progenitor cells in myelodysplastic syndromes. Blut. 1988 Jul;57(1):45–49. doi: 10.1007/BF00320634. [DOI] [PubMed] [Google Scholar]
  7. Geissler K., Peschel C., Niederwieser D., Strobl H., Goldschmitt J., Ohler L., Bettelheim P., Kahls P., Huber C., Lechner K. Potentiation of granulocyte colony-stimulating factor-induced mobilization of circulating progenitor cells by seven-day pretreatment with interleukin-3. Blood. 1996 Apr 1;87(7):2732–2739. [PubMed] [Google Scholar]
  8. Grandjean P., Jensen B. M., Sandø S. H., Jøgensen P. J., Antonsen S. Delayed blood regeneration in lead exposure: an effect on reserve capacity. Am J Public Health. 1989 Oct;79(10):1385–1388. doi: 10.2105/ajph.79.10.1385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Graziano J. H., Slavkovic V., Factor-Litvak P., Popovac D., Ahmedi X., Mehmeti A. Depressed serum erythropoietin in pregnant women with elevated blood lead. Arch Environ Health. 1991 Nov-Dec;46(6):347–350. doi: 10.1080/00039896.1991.9934401. [DOI] [PubMed] [Google Scholar]
  10. Hernberg S., Nurminen M., Hasan J. Nonrandom shortening of red cell survival times in men exposed to lead. Environ Res. 1967 Nov;1(3):247–261. doi: 10.1016/0013-9351(67)90017-5. [DOI] [PubMed] [Google Scholar]
  11. Koury M. J., Bondurant M. C. Maintenance by erythropoietin of viability and maturation of murine erythroid precursor cells. J Cell Physiol. 1988 Oct;137(1):65–74. doi: 10.1002/jcp.1041370108. [DOI] [PubMed] [Google Scholar]
  12. LEIKIN S., ENG G. Erythrokinetic studies of the anemia of lead poisoning. Pediatrics. 1963 Jun;31:996–1002. [PubMed] [Google Scholar]
  13. Leinders T., van Kleef R. G., Vijverberg H. P. Distinct metal ion binding sites on Ca(2+)-activated K+ channels in inside-out patches of human erythrocytes. Biochim Biophys Acta. 1992 Nov 23;1112(1):75–82. doi: 10.1016/0005-2736(92)90256-l. [DOI] [PubMed] [Google Scholar]
  14. Ludwig H., Fritz E., Kotzmann H., Höcker P., Gisslinger H., Barnas U. Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med. 1990 Jun 14;322(24):1693–1699. doi: 10.1056/NEJM199006143222402. [DOI] [PubMed] [Google Scholar]
  15. Lutton J. D., Abraham N. G., Drummond G. S., Levere R. D., Kappas A. Zinc porphyrins: potent inhibitors of hematopoieses in animal and human bone marrow. Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1432–1436. doi: 10.1073/pnas.94.4.1432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Muta K., Krantz S. B. Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin. J Cell Physiol. 1993 Aug;156(2):264–271. doi: 10.1002/jcp.1041560207. [DOI] [PubMed] [Google Scholar]
  17. Muta K., Krantz S. B. Inhibition of heme synthesis induces apoptosis in human erythroid progenitor cells. J Cell Physiol. 1995 Apr;163(1):38–50. doi: 10.1002/jcp.1041630106. [DOI] [PubMed] [Google Scholar]
  18. O'Flaherty E. J. Physiologically based models for bone-seeking elements. IV. Kinetics of lead disposition in humans. Toxicol Appl Pharmacol. 1993 Jan;118(1):16–29. doi: 10.1006/taap.1993.1004. [DOI] [PubMed] [Google Scholar]
  19. Osterode W. Hemorheology in occupational lead exposure. Scand J Work Environ Health. 1996 Oct;22(5):369–373. doi: 10.5271/sjweh.156. [DOI] [PubMed] [Google Scholar]
  20. Waldron H. A. The anaemia of lead poisoning: a review. Br J Ind Med. 1966 Apr;23(2):83–100. doi: 10.1136/oem.23.2.83. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Occupational and Environmental Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES